electroCore, Inc.

Company Overview

electroCore, Inc. is a U.S.-based bioelectronic medicine company focused on non-invasive vagus nerve stimulation (nVNS) therapies. The company develops and commercializes handheld neuromodulation devices intended to treat neurological, respiratory, and general wellness conditions without the use of pharmaceuticals or implanted surgical systems. electroCore primarily operates within the medical device, neurology, pain management, and wellness technology industries, with revenue historically driven by prescription therapies and consumer-facing wellness products.

The company’s principal commercial products include the prescription-use gammaCore platform for conditions such as cluster headache and migraine, as well as wellness-oriented products marketed under brands including Truvaga. electroCore has positioned itself around portable, non-invasive stimulation technology designed to provide alternatives or complements to traditional drug therapies. Founded in 2005, the company evolved from early-stage neurostimulation research into a publicly traded commercial-stage medical technology company, expanding from headache-focused therapies into broader neuromodulation and wellness applications through regulatory clearances, direct-to-consumer initiatives, and international distribution partnerships.